Baghdad is all atwitter over the P-5+1 talks with Iran beginning today. A sandstorm kept many European and Western diplomats from landing, but the Iranians were out in full force, with Iranian negotiator Saeed Jalili leading the way.

At the NATO summit in Chicago, the much hoped-for deal between the United States and Pakistan to reopen NATO supply routes through Pakistan did not materialize. The experience of the closure and the negotiations has laid bare the changed relationship between the U.S. and Pakistan.

Export-related jobs are a huge and important driver of the U.S. economy, and the record of the Ex-Im Bank is clear: Using private funds and with minimal exposure to taxpayers, it has been a major driver of U.S. exports and a driver of jobs and corporate profits in the United States.

In the transition from an old dictator to a new one, some observers were losing faith in the Democratic People's Republic of Korea, believing it had lost its magic touch in the arts of dissembling. Others had deeper faith, though, and they were rewarded last week when the State Department proudly announced the umpteenth breakthrough toward the goal of denuclearizing North Korea.

House Republicans have broken the hugely successful spectrum auction authorization first effected in 1993 and also delayed for many years any possibility that digital broadcast spectrum that is almost entirely unused can be repurposed to serve the growing demands for wireless broadband.

The United States has reportedly offered a plea deal to Majid Khan — a hardened al-Qaeda terrorist and close associate of Khalid Sheikh Mohammed — that could see him released from Guantanamo Bay within a few years.

Giving this killer a reduced sentence is outrageous. Khan is no run-of-the-mill terrorist. He...

Legislation to raise the debt ceiling will give the government headroom to operate until 2013. But a temporary ceasefire in this fiscal war will not address the country's longer-run problems. The rating agencies are therefore justified in reconsidering America's triple-A credit rating.

The core of medicine, and medical research, is and must be the patient, and the success of future drug development will depend upon our ability to keep patients in the front of our minds and at the center of our efforts.